Senseonics (OTC:SENH) said today it inked an exclusive distribution agreement with Roche (PINK:RHHBY) for the multi-country commercialization of the Eversense continuous glucose monitor. Under the deal, Roche has the exclusive rights to promote, market and sell the Eversense product portfolio to diabetes clinics and patients in Germany, Italy and the Netherlands, Senseonics said. The Eversense system includes an implanted […]
Roche
Diabetes: FDA OKs 1st glucose meter with insulin calculator
Biotech titan Roche secured a landmark FDA win with clearance for its Accu-Chek Aviva Expert blood glucose meter, the 1st of its kind with a built-in insulin calculator to help guide patient therapy.
Press Release: ACCU-CHEK Aviva Expert, the first and only stand-alone blood glucose meter system with a built-in insulin calculator, is now available
Medtech personnel moves for the week of Mar. 10, 2014
ConMed proxy war gets ugly
February 28, 2014 by Brad Perriello
The proxy war over control of the board at ConMed turned ugly this week after serious allegations surfaced against 1 of the medical device company’s nominees for director.
Madaus is new CEO at Carlyle’s Ortho-Clinical Diagnostics
The Carlyle Group said it tapped Martin Madaus to take over as CEO of the Ortho-Clinical Diagnostics business it’s acquiring from Johnson & Johnson (NYSE:JNJ).
Ex-Millipore CEO Madaus steps down from Covidien board
Johnson & Johnson shops Ortho Clinical Diagnostics unit
Roche dishes out $220M for Constitution Medical Investors
Biotech titan Roche acquired Boston, Mass.-based medical device company Constitutional Medical Investors for a reported $220 million plus possible milestones.
FDA green-lights 1st HbA1cDx diabetes test | MassDevice.com On Call
MASSDEVICE ON CALL — The FDA this week officially approved Swiss healthcare giant Roche‘s COBAS INTEGRA 800 Tina-quant HbA1cDx assay as a test for diabetes.
The test has been in use as a diagnostic tool off-label, but has been officially marketed only as a means of monitoring blood glucose control.
The strange case of the diabetes market
Diabetes: Roche wins FDA nod for combo glucose meter and insulin pump
Roche (PINK:RHHBY) touted a new win for its Accu-Chek line of diabetes management devices, this time for the Combo system which unites a blood glucose meter and an insulin pump.
The meter and pump can seamlessly transmit data back and forth via Bluetooth, allowing for remote insulin delivery and providing guidance on dosage levels.
